Forge Biologics

The speaker says providing a visual restoration treatment option for patients with retinitis pigmentosa is central to the mission.

Forge Biologics offers career opportunities related to gene therapy manufacturing.

Adam Davis is Forge Biologics' vice president of analytical development, leading product-specific and platform method development for characterization, release, and stability testing. He has over 20 years of experience in recombinant adeno-associated viral vector development, process development, and manufacturing.

Christopher Shilling is Chief Regulatory Officer at Forge Biologics. He has over 20 years of experience developing gene therapies and in regulatory affairs, pharmacology, toxicology, and project management.

Frank Agbogbo is Forge Biologics' vice president of process development, responsible for rAAV process development and plasmid DNA production. He has 20 years of experience in process development, biotechnology, gene therapy, and cell therapy.

Liza Lewis is Vice President of Human Resources at Forge Biologics, overseeing talent acquisition, learning and development, and core HR practices. She has over a decade of experience in HR leadership roles.

The company supports gene therapy developers with manufacturing needs.

New pathways are forged together. Let’s build what’s next in gene therapy.

Forge Biologics provides AAV manufacturing and support at a cGMP facility.

Forge Biologics, Inc. website Privacy Policy.